IHWM
RGNX icon

Iron Horse Wealth Management’s Regenxbio RGNX Stock Holding History

Iron Horse Wealth Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$821 Hold
100
– – ﹤0.01% 531
2025
Q1 		$715 Hold
100
– – ﹤0.01% 537
2024
Q4 		$773 Hold
100
– – ﹤0.01% 451
2024
Q3 		$1.05K Buy
+100
New +$1.22K ﹤0.01% 433

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Iron Horse Wealth Management's RGNX Position: Q2 2025 in Review

Iron Horse Wealth Management held its Regenxbio (RGNX) position steady in Q2 2025 at 100 shares worth $821. The position accounts for ﹤0.01% of the portfolio, ranked #531.

Iron Horse Wealth Management first reported a position in RGNX in Q3 2024 and has held it in 4 quarters since. The position peaked at $1.05K in Q3 2024. 159 funds tracked by Wall St. Rank hold RGNX as of Q2 2025.

  • Iron Horse Wealth Management held 100 shares of Regenxbio worth $821 as of Q2 2025.
  • Iron Horse Wealth Management left its Regenxbio share count unchanged in Q2 2025.
  • Regenxbio made up ﹤0.01% of Iron Horse Wealth Management's portfolio in Q2 2025, its #531 holding.
  • Iron Horse Wealth Management first reported a position in Regenxbio in Q3 2024 and has held it in 4 quarters since.
  • Iron Horse Wealth Management's Regenxbio position peaked at $1.05K in Q3 2024.
  • 159 funds tracked by Wall St. Rank held Regenxbio as of Q2 2025.

Based on Iron Horse Wealth Management's 13F filing for Q2 2025, filed 22 Jul 2025.